Dr Sarah Mitchell, PhD
Pharmacology and Peptide Therapeutics — King's College London
Profile last reviewed: 2026-05-20
Dr Mitchell holds a PhD in Pharmacology from King's College London and has spent over 15 years researching peptide mechanisms of action and drug delivery systems. She leads our content review process for all peptide profiles and mechanism articles, ensuring pharmacology claims are grounded in published evidence.
Credentials
- PhD, Pharmacology — King's College London
- Fellow of the Higher Education Academy (FHEA)
- 15+ years researching peptide mechanisms of action and drug delivery
Professional registrations
- British Pharmacological Society: Member
- Higher Education Academy: Fellow (FHEA)
Academic and learned-society registrations only. No clinical prescribing registration applies to this reviewer's role.
Role on the editorial board
Lead reviewer for peptide profile pharmacology and mechanism-of-action content. Reviews receptor-binding, pharmacokinetics, drug-delivery, and structure-activity claims across the peptide library.
Conflict of interest disclosures
- No equity in peptide manufacturers, online clinics, or research-chemical suppliers.
- No paid consulting or speaker arrangements with peptide-product companies.
- Has previously received public-sector research funding (UKRI / MRC) for unrelated pharmacology work; disclosed transparently.
Disclosures are reviewed annually and updated at the date shown above. See the conflict-of-interest policy for the wider framework.
Sections reviewed
- All peptide-profile pages — mechanism of action sections
- Science section (receptor binding, pharmacokinetics, drug delivery)
- Evidence grading methodology — pharmacology component
Citation policy
Pharmacology and mechanism claims must trace to peer-reviewed published research. Animal-model evidence is acknowledged as such and not extrapolated to human-outcome claims. Mechanism diagrams are simplifications and are labelled as such.
The site-wide methodology is documented in our evidence grading methodology and editorial standards.
About the editorial board
Peptide Authority’s editorial board is responsible for the accuracy, evidence-grading, and UK regulatory framing of the content on this site. Read more about how we work in editorial standards and the corrections policy.
Other reviewers
- Dr James Harrington, MBChB, MRCP — Clinical Endocrinology
- Dr Elena Kowalski, MSc, PhD — Molecular Biology and Immunology
- Dr David Chen, PharmD — Clinical Pharmacy and Regulatory Affairs